See more : Opus Magnum Ameris, Inc. (OPUS) Income Statement Analysis – Financial Results
Complete financial analysis of China Risun Group Limited (1907.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of China Risun Group Limited, a leading company in the Chemicals industry within the Basic Materials sector.
- Maha Rashtra Apex Corporation Limited (MAHAPEXLTD.BO) Income Statement Analysis – Financial Results
- HolidayCheck Group AG (0G8Z.L) Income Statement Analysis – Financial Results
- Beiqi Foton Motor Co., Ltd. (600166.SS) Income Statement Analysis – Financial Results
- Swarna Securities Limited (SWRNASE.BO) Income Statement Analysis – Financial Results
- Principal Solar, Inc. (PSWW) Income Statement Analysis – Financial Results
China Risun Group Limited (1907.HK)
About China Risun Group Limited
China Risun Group Limited, together with its subsidiaries, produces, sells, and distributes coke, coking chemicals, and refined chemicals in the People's Republic of China. The company operates through four segments: Coke and Coking Chemicals Manufacturing, Refined Chemicals Manufacturing, Operation Management, and Trading. Its coking and refined chemical products include crude benzene, industrial naphthalene phthalic anhydride, coke oven gas methanol, coal-tar pitch, and caprolactam. The company also offers operation management service to the third-party coke and chemical companies, as well as training on safety management and operational skills services. In addition, it trades in coke, coking chemical, and refined chemical products; and engages in real estate development activities. The company serves companies in the iron and steel, non-ferrous, coking, and chemical industries. It also exports its products. The company was formerly known as China Risun Coal Chemicals Group Limited and changed its name to China Risun Group Limited in July 2018. China Risun Group Limited was founded in 1995 and is headquartered in Beijing, the People's Republic of China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 46.07B | 43.14B | 38.43B | 19.78B | 18.84B | 20.58B | 18.66B | 12.22B | 9.99B |
Cost of Revenue | 42.74B | 38.86B | 32.90B | 16.56B | 16.26B | 17.17B | 16.65B | 11.24B | 9.48B |
Gross Profit | 3.32B | 4.28B | 5.53B | 3.22B | 2.58B | 3.41B | 2.01B | 973.41M | 515.25M |
Gross Profit Ratio | 7.22% | 9.91% | 14.39% | 16.29% | 13.71% | 16.57% | 10.75% | 7.97% | 5.16% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.06B | 932.93M | 973.85M | 441.19M | 397.43M | 393.61M | 295.56M | 225.17M | 223.92M |
Selling & Marketing | 1.19B | 985.30M | 942.11M | 789.34M | 778.72M | 727.83M | 700.26M | 546.26M | 527.57M |
SG&A | 2.25B | 1.92B | 1.92B | 1.23B | 1.18B | 1.12B | 995.82M | 771.43M | 751.49M |
Other Expenses | -728.79M | -76.72M | -42.60M | -44.92M | -44.18M | 1.33M | -720.00K | 96.41M | 11.96M |
Operating Expenses | 1.52B | 1.84B | 1.87B | 1.19B | 1.13B | 1.10B | 976.52M | 736.56M | 718.00M |
Cost & Expenses | 44.26B | 40.71B | 34.77B | 17.75B | 17.39B | 18.27B | 17.63B | 11.98B | 10.20B |
Interest Income | 161.86M | 160.62M | 66.57M | 39.52M | 94.88M | 130.07M | 184.18M | 184.52M | 139.27M |
Interest Expense | 1.35B | 997.25M | 904.93M | 532.03M | 465.58M | 596.77M | 624.24M | 528.28M | 485.48M |
Depreciation & Amortization | 2.33B | 1.42B | 1.35B | 738.63M | 652.75M | 577.96M | 544.71M | 536.89M | 405.69M |
EBITDA | 4.37B | 4.63B | 5.45B | 3.22B | 2.19B | 3.10B | 1.57B | 1.01B | 310.36M |
EBITDA Ratio | 9.48% | 10.37% | 14.70% | 16.53% | 14.41% | 17.74% | 11.03% | 10.05% | 2.60% |
Operating Income | 1.81B | 2.72B | 3.54B | 2.14B | 1.68B | 2.62B | 1.18B | 760.03M | -8.50M |
Operating Income Ratio | 3.92% | 6.30% | 9.21% | 10.80% | 8.91% | 12.73% | 6.35% | 6.22% | -0.09% |
Total Other Income/Expenses | -1.13B | -514.63M | -342.51M | -138.24M | 154.00K | 40.84M | -338.37M | -369.19M | -572.32M |
Income Before Tax | 681.75M | 2.20B | 3.20B | 2.00B | 1.68B | 2.66B | 845.94M | 390.84M | -580.82M |
Income Before Tax Ratio | 1.48% | 5.11% | 8.32% | 10.10% | 8.91% | 12.93% | 4.53% | 3.20% | -5.81% |
Income Tax Expense | -307.80M | 343.99M | 601.84M | 296.81M | 305.71M | 533.36M | 80.37M | 35.88M | -73.70M |
Net Income | 860.81M | 1.86B | 2.61B | 1.65B | 1.37B | 2.09B | 754.67M | 359.30M | -507.12M |
Net Income Ratio | 1.87% | 4.30% | 6.80% | 8.35% | 7.29% | 10.15% | 4.04% | 2.94% | -5.07% |
EPS | 0.19 | 0.42 | 0.61 | 0.40 | 0.35 | 0.52 | 0.19 | 0.09 | -0.13 |
EPS Diluted | 0.19 | 0.42 | 0.61 | 0.40 | 0.35 | 0.52 | 0.19 | 0.09 | -0.13 |
Weighted Avg Shares Out | 4.42B | 4.43B | 4.29B | 4.09B | 3.95B | 4.00B | 4.00B | 4.00B | 4.00B |
Weighted Avg Shares Out (Dil) | 4.42B | 4.43B | 4.29B | 4.09B | 3.95B | 4.00B | 4.00B | 4.00B | 4.00B |
Source: https://incomestatements.info
Category: Stock Reports